Advanced Instruments Revenue and Competitors

Norwood, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Advanced Instruments's estimated annual revenue is currently $145.8M per year.(i)
  • Advanced Instruments's estimated revenue per employee is $251,000

Employee Data

  • Advanced Instruments has 581 Employees.(i)
  • Advanced Instruments grew their employee count by -4% last year.

Advanced Instruments's People

NameTitleEmail/Phone
1
General CounselReveal Email/Phone
2
VP, Global MarketingReveal Email/Phone
3
VP, OperationsReveal Email/Phone
4
VP, Global R&DReveal Email/Phone
5
SVP, International MarketsReveal Email/Phone
6
VP Sales, AmericasReveal Email/Phone
7
VP, Global Human ResourcesReveal Email/Phone
8
Director Global OperationsReveal Email/Phone
9
Director, Clinical and Artel Product PortfoliosReveal Email/Phone
10
Associate Director, Biopharma ReagentsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is Advanced Instruments?

Advanced Instruments, Inc. is a privately-held business headquartered in Norwood, Massachusetts, supporting worldwide operations and a comprehensive distribution network of independent dealers. Founded in 1955, the company is the world's foremost authority for the application of freezing-point depression (FPD) technology. Additional technologies have been developed or acquired, making Advanced Instruments a leading supplier of diagnostic testing systems used by medical and industrial laboratories. In addition to branding products with the Advanced Instruments name, the company designs, develops and markets diagnostic products for Fiske Associates, and its wholly owned subsidiaries, Spiral Biotech, Inc. and Delta Instruments. Since the company's inception nearly 50 years ago, laboratory professionals have always looked to Advanced instruments for exceptional customer support and leading-edge tools for the diagnostic laboratory. Innovative solutions for common laboratory problems remain the mission of Advanced Instruments.

keywords:N/A

N/A

Total Funding

581

Number of Employees

$145.8M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Advanced Instruments News

2022-04-20 - Advanced Micro Devices Inc. stock falls Wednesday, underperforms market

INTC, +0.38% rose 0.38% to $48.11, and Texas Instruments Inc. TXN, +0.20% rose 0.20% to $179.42. Trading volume (62.3 M) remained 44.2...

2022-04-20 - Bioprocess Technology Market to Reach US$ 53.7 Bn by ...

The increasing application of advanced instruments in the bioprocessing of recombinant proteins is further catalyzing the market prospects.

2022-04-19 - JCET Group Subsidiary Recognized for Excellence by Texas Instruments

... Advanced Packaging Co., LTD. (JCAP), a subsidiary of JCET Group, has received the Texas Instruments (TI) 2021 Supplier Excellence Award.

2021-08-05 - Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization USA - English España - español

NORWOOD, Mass., Aug. 5, 2021 /PRNewswire/ -- Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characteri ...

2016-11-08 - Windjammer Acquires Advanced Instruments

Windjammer Capital Investors is pleased to announce the acquisition of Advanced Instruments, LLC in partnership with AI’s management team. Terms of the transaction were not disclosed. Founded in 1955 and headquartered in Norwood, MA, Advanced Instruments is a leading designer, manufacturer and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$156.3M7707%N/A
#2
$244.3M9385%N/A
#3
$170.1M12156%N/A
#4
$420.4M13235%N/A
#5
$366.5M302510%$270M